Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
biotech
boston blog main
clinical trials
crispr
editas medicine
life sciences
national blog main
abbvie
akouos
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
cynthia collins
deals
deerfield management
detroit blog main
detroit top stories
drugs
durvalumab
europe blog main
europe top stories
fda
forty seven
fred hutch
gene editing
general atlantic
gilead sciences
What
ceo
2
×
acquisitions
allergan
announced
bio
blessing
bosley
check
clinical
collabs
covid
crispr
cusp
daniel
deal
depart
editas
editing
experimental
gene
gilead
gilead’s
help
humans
introduce
ipo
katrine
medicine
medicines
million
month
o’day
partner
plans
regulatory
roundup
sciences
test
therapy
transformative
Language
unset
Current search:
allergan
×
ceo
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
